Follistatin does not influence the course of Escherichia coli K1 sepsis in a mouse model

Shock

Volumn 38, Issue 6, 2012, Pages 615-619

  Dießelberg, Catharina ^a   Ribes, Sandra ^a   Michel, Uwe ^a   Redlich, Sandra ^a   Brück, Wolfgang ^a   Nau, Roland ^a,b   Schütze, Sandra ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Sleep Laboratory   (Germany)

Author keywords

activin A; bacteria; FS; inflammation; LPS; mortality; motor performance; Systemic infection

Indexed keywords

FOLLISTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; MALE; MORTALITY; MOTOR PERFORMANCE; MOUSE; NONHUMAN;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FOLLISTATIN; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; SEPSIS;

EID: 84870053010     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182748d96     Document Type: Article

References (30)

1. Jones KL, de Kretser DM, Patella S, Phillips DJ: Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol 225(1-2):119-125, 2004. (Pubitemid 39297061)
2. Phillips DJ, de Kretser DM, Hedger MP: Activin and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev 20(2):153-164, 2009.
3. Ebert S, Nau R, Michel U: Role of activin in bacterial infections: a potential target for immunointervention? Immunotherapy 2(5):673-684, 2010.
4. Inouye S, Guo Y, DePaolo L, Shimonaka M, Ling N, Shimasaki S: Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin. Endocrinology 129(2): 815-822, 1991.
5. Robertson DM, Klein R, de Vos FL, McLachlan RI, Wettenhall RE, Hearn MT, Burger HG, de Kretser DM: The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun 149(2):744-749, 1987. (Pubitemid 18023042)
6. Shimasaki S, Koga M, Esch F, Mercado M, Cooksey K, Koba A, Ling N: Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing. Biochem Biophys Res Commun 152(2):717-723, 1988.
7. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H: Activin-binding protein from rat ovary is follistatin. Science 247(4944):836-838, 1990.
8. de Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huy-lebroeck K, Verschueren K, van den Eijnden-van Raaij AJ: Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 116(1):105-114, 1996. (Pubitemid 26033023)
9. Demura R, Suzuki T, Tajima S, Mitsuhashi S, Odagiri E, Eto Y, Sugino H, Demura H: Competitive protein binding assay for activin A/EDF using follistatin determination of activin levels in human plasma. Biochem Biophys Res Commun 185(3):1148-1154, 1992.
10. Khoury RH, Wang QF, Crowley WF, Hall JE, Schneyer AL, Toth T, Midgley AR Jr, Sluss PM: Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. J Clin Endocrinol Metab 80(4): 1361-1368, 1995.
11. Klein R, Findlay JK, Clarke IJ, de Kretser DM, Robertson DM: Radioimmunoassay of FSH-suppressing protein in the ewe: concentrations during the oestrous cycle and following ovariectomy. J Endocrinol 137(3):433-443, 1993. (Pubitemid 23209900)
12. Sakamoto Y, Shintani Y, Harada K, Abe M, Shitsukawa K, Saito S: Determination of free follistatin levels in sera of normal subjects and patients with various diseases. Eur J Endocrinol 135(3):345-351, 1996. (Pubitemid 26348740)
13. Wakatsuki M, Shintani Y, Abe M, Liu ZH, Shitsukawa K, Saito S: Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women. J Clin Endocrinol Metab 81(2):630-634, 1996. (Pubitemid 26055676)
14. Ebert S, Phillips DJ, Jenzewski P, Nau R, O-Connor AE, Michel U: Activin A concentrations in human cerebrospinal fluid are age-dependent and elevated in meningitis. J Neurol Sci 250(1-2):50-57, 2006. (Pubitemid 44665929)
15. Michel U, Ebert S, Phillips D, Nau R: Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J Endocrinol 148(5):559-564, 2003. (Pubitemid 36622164)
16. Phillips DJ, Jones KL, Scheerlinck JY, Hedger MP, de Kretser DM: Evidence for activin A and follistatin involvement in the systemic inflammatory response. Mol Cell Endocrinol 180(1-2):155-162, 2001. (Pubitemid 32651681)
17. Michel U, Ebert S, Schneider O, Shintani Y, Bunkowski S, Smirnov A, Stringaris A, Ger-ber J, Brück W, Nau R: Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis. Eur J Endocrinol 143(6):809-816, 2000. (Pubitemid 32066707)
18. Wilms H, Schwark T, Brandenburg L-O, Sievers J, Dengler R, Deuschl G, Lucius R: Regulation of activin A synthesis in microglial cells: pathophysiological implications for bacterial meningitis. J Neurosci Res 88(1):16-23, 2010.
19. Klein R, Clarke IJ, Hedger MP, Robertson DM: Plasma follistatin concentrations increase following lipopolysaccharide administration in sheep. Clin Exp Pharmacol Physiol 23(8):754-755, 1996.
20. Michel U, Schneider O, Kirchhof C, Meisel S, Smirnov A, Wiltfang J, Riekmann P: Production of follistatin in porcine endothelial cells: differential regulation by bacterial compounds and the synthetic glucocorticoid RU 28362. Endocrinology 37(11):4925-4934, 1996. (Pubitemid 26403336)
21. Dohi T, Ejima C, Kato R, Kawamura YI, Kawashima R, Mizutani N, Tabuchi Y, Kojima I: Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology 128(2):411-423, 2005. (Pubitemid 40431093)
22. Hardy CL, O-Connor AE, Yao J, Sebire K, de Kretser DM, Rolland JM, Anderson GP, Phillips DJ, O'Hehir RE: Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma. Clin Exp Allergy 36(7):941-950, 2006. (Pubitemid 43972961)
23. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, Phillips DJ: Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A 104(41):16239-16244, 2007. (Pubitemid 350099391)
24. Ebert S, Goos M, Rollwagen L, Baake D, Zech W-D, Esselmann H, Wiltfang J, Mollenhau-er B, Schliebs R, Gerber J, et al.: Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases. J Neurosci Res 88(5):1124-1136, 2010.
25. Wellmer A, Noeske C, Gerber J, Munzel U, Nau R: Spatial memory and learning deficits after experimental pneumococcal meningitis in mice. Neurosci Lett 296(2-3):137-140, 2000.
26. Salomao R, Brunialti MK, Rapozo MM, Baggio-Zappia GL, Galanos C, Freudenberg M: Bacterial sensing, cell signaling and modulation of the immune response during sepsis. Shock 38(3):227-242, 2012.
27. Nau GJ, Schlesinger A, Richmond JFL, Young RA: Cumulative Toll-like receptor activation in human macrophages treated with whole bacteria. J Immunol 170(10):5203-5209, 2003. (Pubitemid 36554753)
28. Sivagnanam V, Zhu X, Schlichter LC: Dominance of E. coli phagocytosis over LPS in the inflammatory response of microglia. J Neuroimmunol 227(1-2): 111-119, 2010.
29. Ebert S, Gerber J, Bader S, Mühlhauser F, Brechtel K, Mitchell TJ, Nau R: Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination. J Neuroimmunol 159(1-2):87-96, 2005. (Pubitemid 40126180)
30. Remick DG, Ward PA: Evaluation of endotoxin models for the study of sepsis. Shock 24(suppl 1):7-11, 2005.